Grey Wolf Animal Health Corp. (WOLF : TSX-V)
Common Stock
Follow WOLF
WOLF
Grey Wolf Animal Health Corp.
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+1.82%
1 Month
-3.45%
YTD
+26.32%
The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.
Key Statistics
Market Cap
$58.20M
52W High
$1.85
52W Low
$1.22
P/E Ratio
33.60
50 Day MA
$1.69
200 Day MA
$1.60
Beta
0.30
Dividend Yield
-
WA Score
How WOLF stacks up against 947 Canadian stocks
70
out of 99
- Value64
Earnings yield 3.0% (P/E 33.6).
- Quality50
Return on equity 5.0%, profit margin 4.0%.
- Momentum68
26.3% this year, above its 200-day average, 73% of the way up its 52-week range.
- Analysts57
Average analyst target is 33.9% above the price.
- Insidersn/a
Not covered by our SEDI insider data yet.
Each factor is a percentile against Canadian common stocks worth $50M or more on the TSX and TSX Venture (90 = better than 90% of them). Built from exchange prices, company financials, analyst targets and SEDI insider filings. A data summary, not advice. How it works · Top-scoring stocks
Performance history
WOLF returns since 2023
Grey Wolf Animal Health Corp. has traded since Nov 2023 in our data, with 2 up years out of 2 full calendar years. Its deepest fall was −40.0% (Jan 2024 to Jul 2024).
1 year / yr
+40.0%
3 years / yr
—
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2023*+8.8%
- 2024+50.0%
- 2025+18.9%
- 2026*+27.3%
* Partial year (first year of data, or year to date).
$10,000 invested in WOLF
- 1 year ago$14,000
- 2023 (start of our data)$24,706
- Best year
- 2024: +50.0%
- Worst year
- 2025: +18.9%
- All-time high in our data
- $2 on Jun 19, 2026 · now −6.1%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/6/2026 | $1.68 | $1.68 | $1.68 | $1.68 | $1.68 | 578 |
| 10/30/2026 | $1.65 | $1.65 | $1.65 | $1.65 | $1.65 | 2,900 |
| 10/29/2026 | $1.65 | $1.65 | $1.65 | $1.65 | $1.65 | 9,300 |
| 10/27/2026 | $1.65 | $1.70 | $1.65 | $1.70 | $1.70 | 5,500 |
| 10/23/2026 | $1.65 | $1.65 | $1.64 | $1.65 | $1.65 | 23,225 |
| 10/22/2026 | $1.65 | $1.65 | $1.65 | $1.65 | $1.65 | 3,100 |
| 10/21/2026 | $1.66 | $1.66 | $1.65 | $1.65 | $1.65 | 7,900 |
| 10/20/2026 | $1.66 | $1.75 | $1.65 | $1.75 | $1.75 | 49,360 |
| 10/15/2026 | $1.74 | $1.74 | $1.70 | $1.70 | $1.70 | 600 |
| 10/14/2026 | $1.73 | $1.74 | $1.73 | $1.74 | $1.74 | 5,200 |
Analyst Price Targets
Based on analyst covering WOLF · as of Oct 1, 2026
Wall Street analysts forecast WOLF stock price to rise 33.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.25
+33.9% Upside
Current Price
C$1.68
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WOLF's historical volatility
30-Day Vol
43.3%
Annualized
90-Day Vol
49.7%
Annualized
Trend (90d)
-17.1%
Annualized drift
90d Mean
C$1.58
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.65 | C$1.42 – C$1.91 |
| 60 trading days | C$1.61 | C$1.31 – C$1.99 |
| 90 trading days | C$1.58 | C$1.22 – C$2.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Grey Wolf Animal Health Corp.
Grey Wolf Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedative analgesic and reversing agents for companion animals under the SEDAJECT and ATAJECT names; prescription drugs under the THYRO-TABS CANINE name; and wound care products, including medical grade tubes, viscose net dressings, alginate dressing, absorbent foam dressing, superabsorbent dressing, and silicone perforated tapes, as well as medical pet shirt protective wear products, such as pet shirt, pets boot, head cover, and leg sleeves. It also offers disposables comprising syringes, needles, and IV catheters; and nutraceuticals, as well as equine health products. The company was formerly known as Grey Wolf Animal Health Corp. and changed its name to Grey Wolf Health Corp. in June 2026. The company is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $37.65M
- EBITDA
- $6.53M
- Profit Margin
- 4.05%
- ROE (TTM)
- 4.97%
- EPS (Diluted)
- 0.05
- Book Value
- 0.92
Classification
- Sector
- Consumer Discretionary
- Industry
- Diversified Consumer Services
- Group
- Consumer Services
Free newsletter
The Tuesday Stock Pick
One Canadian stock and the case for it
- The name with the biggest gap to analyst targets
- The chart, insider buying and what is driving it
- A plain-English bottom line, no hype
Explore More
Common Questions About WOLF
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.